Neuland Laboratories (NLL) Shares Plunge 13.5% Following Disappointing Q4 Results: A Detailed Analysis

  • Shares of Neuland Laboratories experienced a significant drop of over 13 percent in intra-day trading on Monday, following the release of the pharmaceutical company’s Q4FY24 results, which fell short of market expectations.
  • The company reported a 20 percent year-on-year (YoY) decrease in net profit for Q4FY24, amounting to ₹67.6 crore, compared to ₹84.5 crore in the same quarter the previous year. Total income also saw a 6 percent YoY decline, falling to ₹390.4 crore from ₹415 crore in the corresponding quarter last year.
  • The stock hit a low of ₹6,150, a 13.5 percent drop, distancing itself by over 21 percent from its record high of ₹7,794 on April 18, 2024. Despite this, the stock has still seen a rise of over 114 percent from its 52-week low of ₹2,518.55 on May 12, 2023, and has gained 176 percent in the last year and 18 percent in 2024 YTD.

Neuland Laboratories’ Q4FY24 results disappoint, leading to a significant drop in stock prices. Despite this, the stock has seen considerable growth over the past year.

Operating Front and Net Debt

The firm’s EBITDA in Q4FY24 was down 12 percent to ₹112.2 crore compared to ₹127.8 crore in Q4FY23. Its EBITDA Margin also decreased 202 bps YoY to 28.7 percent in Q4FY24. However, the company’s Net Debt declined to ₹(32.6) crore at the end of Q4FY24, compared to ₹63.0 crore at the end of Q4FY23 and ₹(44.6) crore at the end of Q3FY24.

Financial Year 2023-24 Performance

Despite the disappointing Q4 results, the company’s net profit for the financial year 2023-24 (FY24) soared 83.7 percent YoY to ₹299.6 crore from ₹163.1 crore in FY23. Total income also jumped 30.8 percent YoY to ₹1,571 crore from ₹1,200 crore in FY23. EBITDA surged 68.8 percent YoY to ₹474.5 crore in FY24, and EBITDA Margin increased by 680 bps YoY to 30.2 percent.

Company Outlook and Dividend Announcement

Suchet Davuluri, Vice-Chairman and Chief Executive Officer of Neuland Labs, expressed satisfaction with the company’s FY24 performance, attributing the revenue growth to high growth in the CMS business and steady growth of the Specialty GDS business. The firm’s board of directors has also recommended a final dividend of ₹14/- (140 percent) per equity share for FY24, payable five days after shareholder approval at the 40th Annual General Meeting (AGM).


Despite the disappointing Q4FY24 results, Neuland Laboratories has seen significant growth in the past financial year. The company’s focus on optimizing costs and processes, coupled with growth in its CMS and Specialty GDS businesses, has contributed to this performance. However, the recent drop in stock prices indicates that investors may need to exercise caution and closely monitor the company’s future performance.

Don't forget to enable notifications for our Twitter account and Telegram channel to stay informed about the latest cryptocurrency news.

Latest News

GSFC Shares Plunge Nearly 10% Following 89% Profit Decline in Q1 – Analysis on GSFC’s Financial Health

```html Shares of Gujarat State Fertilizers & Chemicals (GSFC)...

VanEck’s New Bitcoin Fund (BTC) Awaits Approval, Now Listed on DTCC: A Milestone for Cryptocurrency Investments

VanEck's Ethereum ETF progresses towards approval, igniting anticipation...

Uniswap (UNI) Stands Firm Against SEC Allegations, Prepares for Legal Battle

Decentralized exchange giant Uniswap has recently filed a...

PRO Analysis

GSFC Shares Plunge Nearly 10% Following 89% Profit Decline in Q1 – Analysis on GSFC’s Financial Health

```html Shares of Gujarat State Fertilizers & Chemicals (GSFC)...

Gold Slides from Peak: What’s Next for Investors? [Expert Analysis]

As global economic uncertainties persist, gold prices have...

Bitcoin (BTC) and Altcoin Market Update: Comprehensive Analysis for May 22

Bitcoin currently sees a 1.6% decrease, trading at...

Whale Investor Acquires Massive Stakes in WIF and GME Cryptocurrencies: Market Impact Analysis

In the dynamic world of cryptocurrencies, meme coins...

Bank Nifty (BANKNIFTY) Trading Begins Strong at ₹48,113.9: Live Market Updates and Analysis

```html Bank Nifty Share Price Live Updates: Bank Nifty...
Gideon Wolf
Gideon Wolf
GideonWolff is a 27-year-old technical analyst and journalist with extensive experience in the cryptocurrency industry. With a focus on technical analysis and news reporting, GideonWolff provides valuable insights on market trends and potential opportunities for both investors and those interested in the world of cryptocurrency.

GSFC Shares Plunge Nearly 10% Following 89% Profit Decline in Q1 – Analysis on GSFC’s Financial Health

```html Shares of Gujarat State Fertilizers & Chemicals (GSFC) experienced a significant drop following disappointing fourth-quarter results. The company reported a drastic 89 percent...

PNC Infratech (PNCINFRA) Stock Soars 12%, Hits Record High as Leading Bidder in Two Major Projects

```html PNC Infratech Ltd's share price surged by 17% in Wednesday's intraday trading, reaching an all-time high of ₹535.50 on the...

Suzlon Energy (SUZLON) Soars 5% on Securing Lucrative New Wind Energy Project

```html Suzlon Energy, India's leading renewable energy solutions provider, saw its shares surge by 5% today, reaching ₹46.25, following a significant new order announcement. ...